In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Precarious Union: Combining Proprietary and Generic Businesses

Executive Summary

The major generics companies, flush with cash from the recent plethora of patent expirations, are all forging ahead in the proprietary business in order to boost margins and even out the volatile revenues and earnings inherent in their core business. They're pursuing, by and large, strategies that don't take them far from their core expertise and involve reformulating known compounds. Some companies have had moderate success, but weaving together two such disparate businesses is a challenge.
Advertisement

Related Content

Pliva: Two Steps Forward, One Step Back?
Authorized Generics: Band-Aid or Strategy?
From Generics to Brands: Barr's Women's Health Franchise
Watson's Strategy for Beating the Big Boys
Lilly & Boehringer: When You Gotta Partner, You Gotta Partner
Biogenerics Are Coming and They're Not the Generics We Know
Teva's Growth Momentum
Contraceptive Conjugation
Teva's Growth Trend
Generic Update: Brand-Name Companies Vs. Independents

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001970

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel